Unnamed: 0,title,date,stock,sentiment
1107720.0,16 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2020-04-29 07:35:00-04:00,RTIX,neutral
1107721.0,82 Biggest Movers From Yesterday,2020-04-29 04:30:00-04:00,RTIX,neutral
1107722.0,56 Stocks Moving In Tuesday's Mid-Day Session,2020-04-28 12:27:00-04:00,RTIX,neutral
1107723.0,Mid-Morning Market Update: Markets Open Higher; PepsiCo Profit Beats Estimates,2020-04-28 10:13:00-04:00,RTIX,positive
1107724.0,"RTI Surgical 8-K Shows Co.'s Audit Committee Concluded Co. Will Restate Previously-Issued Audited Financial Statements For Years 2014-2018, Qtr. Periods",2020-04-09 06:11:00-04:00,RTIX,neutral
1107725.0,Stocks That Hit 52-Week Lows On Monday,2020-03-23 10:34:00-04:00,RTIX,negative
1107726.0,"RTI Surgical Holdings, Inc. To Delay Form 10-K filing For Fiscal Year 2019",2020-03-16 16:10:00-04:00,RTIX,negative
1107727.0,"RTI Surgical Announces Expiration Of Its Hart-Scott-Rodino Waiting Peridof With Respect To The Sale Of OEM Business As Of 11:59 P.M. EST On Febuary 28, 2020",2020-03-03 07:49:00-05:00,RTIX,positive
1107728.0,"Cantor Fitzgerald Reiterates Overweight on RTI Surgical Hldgs, Raises Price Target to $6",2020-01-17 08:56:00-05:00,RTIX,negative
1107729.0,80 Biggest Movers From Yesterday,2020-01-15 04:48:00-05:00,RTIX,neutral
1107730.0,Mid-Afternoon Market Update: Dow Turns Lower; Stemline Therapeutics Shares Plummet,2020-01-14 14:15:00-05:00,RTIX,neutral
1107731.0,Mid-Day Market Update: GameStop Falls Following Soft 2019 Holiday Sales; RTI Surgical Shares Climb,2020-01-14 12:26:00-05:00,RTIX,positive
1107732.0,48 Stocks Moving In Tuesday's Mid-Day Session,2020-01-14 12:06:00-05:00,RTIX,neutral
1107733.0,Mid-Morning Market Update: Markets Mostly Lower; JPMorgan Tops Q4 Expectations,2020-01-14 10:27:00-05:00,RTIX,positive
1107734.0,13 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2020-01-14 07:44:00-05:00,RTIX,neutral
1107735.0,26 Stocks Moving in Tuesday's Pre-Market Session,2020-01-14 07:41:00-05:00,RTIX,neutral
1107736.0,RTI Surgical shares are trading higher after the company announced it will sell its OEM Business for $490 million. The company also issued preliminary Q4 and FY19 sales guidance above analyst estimates.,2020-01-14 07:16:00-05:00,RTIX,positive
1107737.0,"RTI Surgical Holdings, Inc. Shares To Resume Trade At 4:45 p.m. EDT",2020-01-13 16:18:00-05:00,RTIX,positive
1107738.0,"RTI Surgical Holdings Sees Prelim. Q4 Sales $79M-$80M vs $78.11M Est., Sees PRelim. FY19 Sales $307M-$308M vs $306.25M Est.",2020-01-13 16:16:00-05:00,RTIX,neutral
1107739.0,RTI Surgical Holdings To Sell OEM Business For $490M,2020-01-13 16:15:00-05:00,RTIX,neutral
1107740.0,"RTI Surgical Holdings Shares Halted, News Pending",2020-01-13 16:13:00-05:00,RTIX,positive
1107741.0,RTI Surgical Announces The Spine Journal's Publication Of In Vivo TETRAfuse 3D Technology PEKK Study,2019-12-17 07:11:00-05:00,RTIX,neutral
1107742.0,RTI Surgical Holdings 13D Shows Glen Capital Partners Holds ~4.65M Share Stake In Co. Compared With ~4.85M Previous,2019-11-06 17:26:00-05:00,RTIX,positive
1107743.0,Stocks That Hit 52-Week Lows On Tuesday,2019-11-05 11:18:00-05:00,RTIX,negative
1107744.0,Stocks That Hit 52-Week Lows On Monday,2019-11-04 14:45:00-05:00,RTIX,negative
1107745.0,"RTI Surgical Cuts FY19 Guidance: Sales From $325M-$335M To $305M-$310M vs $323.4M Estimate, Adj. EBITDA From $36M-$40M to $30M-$34M",2019-10-31 09:20:00-04:00,RTIX,negative
1107746.0,"RTI Surgical Hldgs Q3 Adj. EPS $(0.010), Inline, Sales $76.129M Miss $79.47M Estimate",2019-10-31 07:52:00-04:00,RTIX,negative
1107747.0,Stocks That Hit 52-Week Lows On Tuesday,2019-10-08 12:02:00-04:00,RTIX,negative
1107748.0,Stocks That Hit 52-Week Lows Of Monday,2019-10-07 11:09:00-04:00,RTIX,negative
1107749.0,Stocks That Hit 52-Week Lows On Friday,2019-10-04 14:32:00-04:00,RTIX,negative
1107750.0,Stocks That Hit 52-Week Lows On Thursday,2019-10-03 13:03:00-04:00,RTIX,negative
1107751.0,Stocks That Hit 52-Week Lows On Wednesday,2019-10-02 10:55:00-04:00,RTIX,negative
1107752.0,Stocks That Hit 52-Week Lows On Tuesday,2019-10-01 14:35:00-04:00,RTIX,negative
1107753.0,RTI Surgical Announces Commercial Launch Of The CervAlign Anterior Cervical Plate System,2019-09-24 07:07:00-04:00,RTIX,neutral
1107754.0,RTI Surgical Highlights First Spine Surgery Using HPS 2.0 Hybrid Performance System,2019-09-17 16:33:00-04:00,RTIX,neutral
1107755.0,"Benzinga's Top Upgrades, Downgrades For September 17, 2019",2019-09-17 10:38:00-04:00,RTIX,positive
1107756.0,"Yesterday Sidoti & Co. Initiated Coverage On RTI Surgical Hldgs with Buy Rating, Announced $5 Price Target",2019-09-17 09:01:00-04:00,RTIX,neutral
1107757.0,Stocks That Hit 52-Week Lows On Friday,2019-08-16 11:44:00-04:00,RTIX,negative
1107758.0,Stocks That Hit 52-Week Lows On Thursday,2019-08-15 11:29:00-04:00,RTIX,negative
1107759.0,Stocks That Hit 52-Week Lows On Wednesday,2019-08-14 12:46:00-04:00,RTIX,negative
1107760.0,Stocks That Hit 52-Week Lows On Tuesday,2019-08-13 11:08:00-04:00,RTIX,negative
1107761.0,Stocks That Hit 52-Week Lows Of Monday,2019-08-12 11:14:00-04:00,RTIX,negative
1107762.0,Stocks That Fell Through 52-Week Lows Wednesday,2019-08-07 14:22:00-04:00,RTIX,negative
1107763.0,"RTI Surgical Hldgs Q2 Adj. EPS $0.01 Beats $(0.01) Estimate, Sales $82.307M Beat $81.24M Estimate",2019-08-01 07:14:00-04:00,RTIX,neutral
1107764.0,"Cantor Fitzgerald Initiates Coverage On RTI Surgical Hldgs with Overweight Rating, Announces $7 Price Target",2019-05-30 07:35:00-04:00,RTIX,negative
1107765.0,RTI Surgical S-3 Shows Registration For $100M Mixed Securities Offering,2019-05-23 17:21:00-04:00,RTIX,positive
1107766.0,RTI Surgical Reaffirms FY2019 Sales Guidance of $325M-335M versus $326.22M Est.,2019-05-02 08:15:00-04:00,RTIX,neutral
1107767.0,"RTI Surgical Q1 EPS $0.01 Beats $(0.01) Estimate, Sales $69.741M Beat $69.02M Estimate",2019-05-02 08:14:00-04:00,RTIX,neutral
1107768.0,"Shares of several healthcare stocks are trading higher in a potential rebound from last week's selloff. In an upgrade of HCA Healthcare, Raymond James analysts noted the selloff was 'based on legislation that has almost no chance of passing'",2019-04-23 11:52:00-04:00,RTIX,positive
1107769.0,RTI Surgical Enrolls First Patient In FORTE Clinical Study Of Fortilink Interbody Fusion Device With TETRAfuse 3D Technology,2019-03-20 07:06:00-04:00,RTIX,neutral
1107770.0,RTI Surgical Shareholders Approve Paradigm Spine Acquisition,2019-03-07 16:48:00-05:00,RTIX,neutral
1107771.0,"RTI Surgical Q4 EPS $0.03 Beats $0.01 Estimate, Sales $71.22M Beat $70.34M Estimate",2019-02-28 07:13:00-05:00,RTIX,neutral
1107772.0,"RTI Surgical Announces US Nonprofit, HealthPartners, Makes Positive Coverage Decision for Minimally Invasive Sacroiliac Joint Fusion Surgery",2018-11-19 07:02:00-05:00,RTIX,positive
1107773.0,"RTI Surgical Reports Purchase Of Paradigm Spine For $300M In Cash, Stock",2018-11-01 17:20:00-04:00,RTIX,neutral
1107774.0,RTI Surgical Narrows FY2018 Sales Guidance from $280.0M-290.0M to $280.0M vs $283.50M Est,2018-11-01 07:25:00-04:00,RTIX,neutral
1107775.0,"RTI Biologics, Inc. Q3 EPS $0.03 Beats $0.01 Estimate, Sales $69.064M Beat $68.64M Estimate",2018-11-01 07:24:00-04:00,RTIX,neutral
1107776.0,"RTI Surgical Sees FY18 Sales $280-$290M vs $283M Est., Adj. EBITDA $32-$38M",2018-08-02 07:11:00-04:00,RTIX,neutral
1107777.0,"RTI Surgical Q2 Adj. EPS $0.03 Beats $0.01 Estimate, GAAP EPS $(0.10), Sales $70.685M Beat $70.19M Estimate",2018-08-02 07:11:00-04:00,RTIX,neutral
1107778.0,"RTI Surgical, Aziyo Biologics Announce Exclusive Agreement to Distribute ViBone for Spine and Other Orthopedic Procedures",2018-08-01 20:10:00-04:00,RTIX,positive
1107779.0,RTI Surgical Sees FY18 Sales $280-$290M vs $283M Est.,2018-05-03 07:36:00-04:00,RTIX,neutral
1107780.0,"RTI Surgical Q1 EPS $0.01, Inline, Sales $69.9M Beat $68.73M Estimate",2018-05-03 07:36:00-04:00,RTIX,neutral
1107781.0,RTI Surgical Says Has Provided 8M+ Biologic Implants Processed Through Co.'s Proprietary Sterilization Processes With 0 Confirmed Incidence Of Infection,2018-04-04 07:01:00-04:00,RTIX,neutral
1107782.0,RTI Surgical Highlights Study Which Showed SImmetry System In Sacroiliac Joint Fusion Significantly Reduced Range Of Motion Published In The Spine Journal,2018-03-28 07:12:00-04:00,RTIX,neutral
1107783.0,"RTI Surgical Earlier Reported Q4 Adj. EPS $(0.03), Inline, Net Loss $8.6M, Sales $70.82M vs $69.7M Est.; Sees FY18 Sales $280M-290M vs $281.07M Est.",2018-03-01 10:02:00-05:00,RTIX,negative
1107784.0,RTI Surgical Reports Data From Sacroiliac Joint Fusion and Pain Reduction with the SImmetry® System Showed Device Enabled SI Joint Arthrodesis,2018-01-24 07:04:00-05:00,RTIX,negative
1107785.0,"RTI Surgical Sees Long-Term Sales $500M+, EBITA Margin 20+%",2018-01-05 07:01:00-05:00,RTIX,neutral
1107786.0,RTI Surgical Sees FY18 Sales $280M-$290M vs $281M Est.,2018-01-05 07:01:00-05:00,RTIX,neutral
1107787.0,"RTI Surgical Reports Purchase Of Zyga Technology, No Terms Disclosed",2018-01-04 16:30:00-05:00,RTIX,negative
1107788.0,"RTI Surgical Says it Received a Letter from the FDA After the FDA Inspected its Alachua, Florida Facility",2017-11-14 08:11:00-05:00,RTIX,neutral
1107789.0,RTI Surgical Sees FY17 Adj. EPS $0.05-$0.07 vs $0.03 Est.,2017-11-02 07:47:00-04:00,RTIX,neutral
1107790.0,"RTI Surgical Reports Q3 EPS $0.01 vs $0.01 Est., Sales $66.68M vs $65.38M Est.",2017-11-02 07:46:00-04:00,RTIX,neutral
1107791.0,"RTI Surgicasl Director Valeriani Buys 5,500 @ Avg Price: $4.70 -Form4",2017-08-23 10:39:00-04:00,RTIX,neutral
1107792.0,"UPDATE: RTI Surgical Cuts FY17 Adj. EPS From $0.05-$0.10 To $0.04-$0.08 vs $0.08 Est., Sales From $274M-$285M To $274M-$280M vs $281.4M Est.",2017-08-08 08:05:00-04:00,RTIX,negative
1107793.0,RTI Surgical Cuts Outlook,2017-08-08 08:04:00-04:00,RTIX,negative
1107794.0,"RTI Surgical Reports Q2 Adj. EPS $0.02, Inline, Sales $72.1M vs $69.9M Est.",2017-08-08 08:04:00-04:00,RTIX,neutral
1107795.0,RTI Surgical Reports Divestiture Of Cardiothoracic Closure Unit To A&E Medical For Up To $60M,2017-08-03 16:50:00-04:00,RTIX,neutral
1107797.0,RTI Surgical Sees FY17 EPS $0.05-$0.10 vs $0.02 Est.,2017-04-27 08:13:00-04:00,RTIX,neutral
1107798.0,"RTI Surgical Reports Q1 EPS $(0.05), Adj. EBITDA $6.5M, Sales $69.9M vs $67M Est.",2017-04-27 08:13:00-04:00,RTIX,neutral
1107799.0,"RTI Sees FY17 Adj. EPS $0.05-$0.10 vs $0.08 Est., Sales $274M-$285M vs $282M Est.",2017-02-23 08:05:00-05:00,RTIX,neutral
1107800.0,"RTI Surgical Reports Q4 EPS $0.01 vs $(0.01) Est., Sales $71.3M vs $67.2M Est.",2017-02-23 08:05:00-05:00,RTIX,neutral
1107801.0,Michael Krensavage Reports 7.2% Stake in RTI Surgical in 13D,2017-02-17 07:04:00-05:00,RTIX,neutral
1107802.0,RTI Surgical Names Camille Farhat CEO,2017-01-26 08:37:00-05:00,RTIX,neutral
1107803.0,RTI Surgical Names Robert P. Jordheim Interim CEO,2016-12-14 08:03:00-05:00,RTIX,neutral
1107804.0,RTI Surgical Lowers FY 2016 Guidance From $0.09 - $0.12 to $0.01 - $0.03 vs $0.10 est,2016-10-25 07:52:00-04:00,RTIX,negative
1107805.0,"RTI Surgical Q3 EPS $0.00 vs $0.03 est, Revenue $66.5M vs $66.9M est",2016-10-25 07:50:00-04:00,RTIX,neutral
1107806.0,"RTI Surgical Reports Received Regulatory Clearances, Expands Distribution of nanOss Bioactive in Australia, Europe",2016-09-19 08:01:00-04:00,RTIX,positive
1107807.0,"RTI Surgical CEO Brian Hutchison To Retire, Will Remain At Company Until New CEO Is Named",2016-08-15 09:01:00-04:00,RTIX,neutral
1107808.0,Krensavage Poses Questions to RTI Surgical in Open Letter,2016-07-28 08:03:00-04:00,RTIX,neutral
1107809.0,Craig-Hallum Downgrades RTI Surgical to Hold,2016-07-28 07:19:00-04:00,RTIX,neutral
1107810.0,RTI Surgical Lowers FY16 Rev. From $282-$290M To $274-$280M,2016-07-27 07:40:00-04:00,RTIX,negative
1107811.0,"RTI Surgical Reports Q2 EPS $(0.05) vs. Est. $0.03, Rev. $7.6M vs. Est. $66.5M",2016-07-27 07:39:00-04:00,RTIX,neutral
1107812.0,"Glass Lewis Announces Support of Krensavage's Call for Change on RTI Board, Recommends Holders Vote on GREEN Proxy Card",2016-05-18 11:31:00-04:00,RTIX,positive
1107813.0,Krensavage Asset Mgmt on RTI: Announces Vote on GREEN Proxy Card,2016-05-17 09:07:00-04:00,RTIX,positive
1107814.0,RTI Surgical Reports ISS Has Recommended Holders Vote FOR All Director Nominees on WHITE Proxy Card,2016-05-16 16:40:00-04:00,RTIX,positive
1107815.0,"RTI Surgical Sees Q2 Rev. $66-$67M vs. Est. $70M, EPS ~$0.03 vs. Est. $0.05; FY16 Rev. $282-$290M, EPS $0.18-$0.21 vs. Est. $0.19",2016-04-28 07:45:00-04:00,RTIX,neutral
1107816.0,"RTI Surgical Reports Q1 EPS $0.03 vs. Est. $0.03, Rev. $67.4M vs. Est. $65M",2016-04-28 07:44:00-04:00,RTIX,neutral
1107817.0,"RTI Surgical Reports Distribution of Proxy Material, Letter to Holders",2016-04-19 08:37:00-04:00,RTIX,neutral
1107818.0,UPDATE: Krensavage Calls For Replacement Of Chief Executive Brian Hutchison Due To Shortfalls In RTI Performance & Questions Directors Selection Independence,2016-04-06 08:54:00-04:00,RTIX,neutral
1107819.0,RTI Surgical Announces Has Rejected Krensavage's Efforts to Improve Corp. Governance,2016-04-06 08:54:00-04:00,RTIX,negative
1107820.0,"Krensavage Applauds RTI Surgical's Appointment of New Chairman, Nominates Four Highly-Qualified Directors to Company's Board",2016-03-02 08:38:00-05:00,RTIX,positive
1107821.0,"Michael Krensavage Delivered Letter To RTI Surgical, Asks For Jeff GOldberg, Mark Stolper, John Watts, & Frank Williams To Join Board",2016-02-23 17:35:00-05:00,RTIX,positive
1107822.0,"RTI Surgical Sees FY16 EPS $0.18-$0.21 vs $0.23 Est., Sales $280M-$290M vs $288.5M Est.",2016-02-16 08:01:00-05:00,RTIX,neutral
1107823.0,"RTI Surgical Sees Q1 EPS ~$0.03 vs $0.06 Est., Sales ~$65M-$66M vs $69.7M Est.",2016-02-16 08:01:00-05:00,RTIX,neutral
1107824.0,"RTI Surgical Reports Q4 Adj. EPS $0.09 vs $0.05 Est., Sales $76.1M vs $68.3M Est.",2016-02-16 08:00:00-05:00,RTIX,neutral
1107825.0,13D Filing Shows RTI Surgical Holders Glen Capital Partners Focus Fund LP Holds 8.4% Stake As Of Jan 19,2016-01-19 16:29:00-05:00,RTIX,neutral
1107826.0,RTI Surgical Sees Q4 Sales $76.1M vs $68.3M Est.; FY15 Sales $282.3M vs $274M Est.,2016-01-08 08:05:00-05:00,RTIX,neutral
1107827.0,"UPDATE: RTI Surgical Sees Q4 EPS ~$0.05 vs $0.07 Est., Sales $68M-$69M vs $75M Est.; Cuts FY15 EPS Outlook from $0.20-$0.23 to ~$0.19 vs $0.21 Est., Sales from $282M-$286M to $274M-$275M vs $284.5M Est.",2015-10-29 08:10:00-04:00,RTIX,negative
1107828.0,"RTI Surgical Reports Q3 EPS $0.05, Inline, Sales $66.5M vs $69.6M Est.",2015-10-29 08:09:00-04:00,RTIX,neutral
1107829.0,TRI Surgical Reports Inline Q3 EPS $0.05,2015-10-29 08:03:00-04:00,RTIX,neutral
1107830.0,"RTI Surgical Reports Q2 EPS $0.05 Vs Est $0.04, Sales $71.6M Vs Est $70.57M; Sees Inline Q3 EPS $0.05 & Revs $69M-$70M Vs Est $70.79M; Sees FY EPS $0.20-$0.23 vs Est $0.21 & Revs $282-$286M Vs Est $284.44M",2015-07-30 08:06:00-04:00,RTIX,neutral
1107831.0,"Sidoti & Co. Initiates Coverage on RTI Surgical at Buy, Announces $9.00 PT",2015-05-21 09:25:00-04:00,RTIX,neutral
1107832.0,RTI Surgical Reaffirms FY Guidance,2015-05-06 15:21:00-04:00,RTIX,neutral
1107833.0,"RTI Surgical Raises 2015 Guidance, Sees Q1 EPS $0.19-$0.23 Up From $0.17-$0.22 & Revs $2481M-$286M Up From $279M-$285M",2015-04-23 08:24:00-04:00,RTIX,neutral
1107834.0,"RTI Surgical Reports Q1 GAAP EPS $0.05 vs $0.03 Est., Sales $68M vs $66.4M Est.; Sees Q2 EPS ~$0.04, Inline, FY EPS $0.19-$0.23 vs $0.19 Est.",2015-04-23 08:03:00-04:00,RTIX,neutral
1107835.0,"RTI Surgical Announces Agreement with Novation, One of the Nation's Leading Healthcare Services Companies",2015-04-13 09:01:00-04:00,RTIX,positive
1107836.0,RTI Surgical Announces Deal with Novation,2015-04-13 09:00:00-04:00,RTIX,neutral
1107837.0,"RTI Surgical Reports Q4 EPS $0.05 Vs Est $0.04, Sales $70.9M Vs Est $65.02M",2015-02-12 08:05:00-05:00,RTIX,neutral
1107838.0,"RTI Biologics, Inc. Reports Q3 EPS of $0.03 vs $0.02 Est; Revenue of $65.20M vs $61.71M Est",2014-10-30 08:02:00-04:00,RTIX,neutral
1107839.0,Shirley A. Weis Joins RTI Surgical Board Of Directors ,2014-10-22 16:14:00-04:00,RTIX,neutral
1107840.0,15 US Penny Stocks With Strong Q3 Earnings,2014-10-14 08:21:00-04:00,RTIX,positive
1107841.0,UPDATE: RTI Surgical Announces Received Letter from FDA Related to map3 Cellular Allogeneic Bone Graft,2014-10-09 13:50:00-04:00,RTIX,neutral
1107842.0,RTI Surgical Announces Received Letter from FDA Related to map3 Cellular Allogeneic Bone Graft,2014-10-09 13:49:00-04:00,RTIX,neutral
1107843.0,InterMune Surges On Announcement Of Acquisition By Roche; Greif Shares Slide,2014-08-25 13:01:00-04:00,RTIX,positive
1107844.0,Morning Market Movers ,2014-07-24 09:44:00-04:00,RTIX,neutral
1107845.0,"RTI Biologics, Inc. Sees FY2014 Sales $258.0M-261.0M",2014-07-24 08:07:00-04:00,RTIX,neutral
1107846.0,"RTI Biologics, Inc. Sees Q3 EPS $0.02; Sees Sales $64.0M-65.0M",2014-07-24 08:06:00-04:00,RTIX,neutral
1107847.0,"RTI Biologics, Inc. Reports Q2 EPS of $0.03 vs $0.02 Est; Revenue of $66.0M vs $59.20M Est",2014-07-24 08:01:00-04:00,RTIX,neutral
1107848.0,"Craig-Hallum Upgrades RTI Biologics, Inc. to Buy, Raises PT to $5.00",2014-04-25 07:50:00-04:00,RTIX,neutral
1107849.0,"Canaccord Genuity Upgrades RTI Biologics, Inc. to Buy, Raises PT to $5.00",2014-04-25 07:50:00-04:00,RTIX,neutral
1107850.0,"RTI Biologics, Inc. Raises FY2014 EPS Guidance from $0.06-0.08 to $0.07-0.09 vs $0.07 Est; Sees Sales $248.0M-253.0M vs $267.90M Est",2014-04-24 08:03:00-04:00,RTIX,neutral
1107851.0,"RTI Biologics, Inc. Sees Q2 Sales $62.0M-63.0M vs $58.0M Est",2014-04-24 08:03:00-04:00,RTIX,neutral
1107852.0,"RTI Biologics, Inc. Reports Q1 EPS of $(0.05) vs $(0.01) Est; Revenue of $60.70M vs $55.43M Est",2014-04-24 08:00:00-04:00,RTIX,neutral
1107853.0,RTI Surgical Wins CE Mark Approval for Fortiva Porcine Dermis,2014-03-11 17:01:00-04:00,RTIX,positive
1107854.0,RTI Surgical Announces Renewal of Deal with Zimmer for Trauma Business,2014-02-19 09:04:00-05:00,RTIX,negative
1107855.0,"RTI Biologics, Inc. Sees FY2014 EPS $0.06-0.08 vs $0.06 Est; Sees Sales $245.0M-250.0M vs $236.90M Est",2014-02-13 08:06:00-05:00,RTIX,neutral
1107856.0,"RTI Biologics, Inc. Sees Q1 EPS $(0.07) vs $0.00 Est; Sees Sales $58.0M-59.0M vs $55.54M Est",2014-02-13 08:06:00-05:00,RTIX,neutral
1107857.0,"RTI Biologics, Inc. Reports Q4 EPS of $(0.15) vs $(0.01) Est; Revenue of $60.50M vs $59.16M Est",2014-02-13 08:03:00-05:00,RTIX,neutral
1107858.0,RTI Surgical Announces Deal to Supply Complete Surgical Specialties Portfolio to Yankee Alliance Members,2014-01-13 09:02:00-05:00,RTIX,neutral
1107859.0,"RTI Biologics Shares Down 2+%, Craig-Hallum Downgraded from Buy to Hold, Cut Target to $3.50",2013-10-21 10:48:00-04:00,RTIX,neutral
1107860.0,"Form 8-K from RTI Surgical Shows Deal with Medtronic for Royalties Related to Allograft Implants, Initial Term Through Dec. 31st, 2017",2013-10-18 16:18:00-04:00,RTIX,neutral
1107861.0,Shares of RTI Surgical to Resume Trade at 9AM EDT,2013-10-16 08:55:00-04:00,RTIX,positive
1107862.0,"UPDATE: RTI Surgical Announces Deal with Medtronic, Includes Transfer Fee Structures, Rights to IP",2013-10-16 08:32:00-04:00,RTIX,neutral
1107863.0,RTI Biologics Shares Halted to Announce: Lowers Q3 Sales Guidance from $59.0M-61.0M to $54.70M vs $57.42M Est,2013-10-16 08:31:00-04:00,RTIX,positive
1107864.0,S-3 Filing from RTI Surgical Shows Co. Has Filed Shelf for Up to 15.34M Shares on Behalf of Selling Holders,2013-09-17 16:48:00-04:00,RTIX,positive
1107865.0,"RTI Surgical Reports Successful Outcome to FDA Inspection of Alachua, FL Facility",2013-09-11 08:01:00-04:00,RTIX,positive
1107866.0,"UPDATE: Canaccord Genuity Downgrades RTI Surgical Following In-Line Revenue, Lowered Guidance",2013-08-07 11:06:00-04:00,RTIX,negative
1107867.0,"Canaccord Genuity Downgrades RTI Biologics, Inc. to Hold, Lowers PT to $3.50",2013-08-07 06:22:00-04:00,RTIX,negative
1107868.0,RTI Surgical Sees Q3 Sales $59-61M vs $50.4M ESt.,2013-08-06 08:07:00-04:00,RTIX,neutral
1107869.0,RTI Surgical Reports Q2 Adj. EPS Breakeven vs $0.03 Est.; Raises FY13 Sales Guidance from $179-182M to $211-215M vs $189.6M Est.,2013-08-06 08:06:00-04:00,RTIX,neutral
1107870.0,RTI Biologics Announces Deal to Buy Pioneer Surgical for $130M in Cash; Shares to Resume Trade at 7:30AM EDT,2013-06-12 07:19:00-04:00,RTIX,positive
1107871.0,"RTI Biologics, Inc. Sees FY2013 EPS $0.17-0.19 vs $0.17 Est; Raises FY2013 Sales Guidance from $178.0M-182.0M to $179.0M-182.0M vs $178.90M Est",2013-04-25 08:14:00-04:00,RTIX,neutral
1107872.0,"RTI Biologics, Inc. Sees Q2 EPS $0.03 vs $0.03 Est; Sees Sales $42.0M-43.0M vs $43.20M Est",2013-04-25 08:14:00-04:00,RTIX,neutral
1107873.0,"RTI Biologics, Inc. Reports Q1 EPS of $0.03 vs $0.02 Est; Revenue of $40.42M vs $38.76M Est",2013-04-25 08:13:00-04:00,RTIX,neutral
1107874.0,RTI Biologics Announces Positive Clinical Results for BioCleanse-Processed BTB Allografts Used in ACL Reconstruction ,2013-03-20 08:33:00-04:00,RTIX,positive
1107875.0,"Roth Capital Downgraded RTI Biologics, Inc. to Neutral, Raised PT to $5.00",2013-02-07 14:36:00-05:00,RTIX,neutral
1107876.0,"RTI Biologics, Inc. Sees Q1 EPS $0.02; Sees Sales $38.0M-39.0M; Sees FY Sales $178-182M",2013-02-07 08:08:00-05:00,RTIX,neutral
1107877.0,"RTI Biologics, Inc. Reports Q4 EPS of $0.02 vs $0.04 Est; Revenue of $44.61M",2013-02-07 08:08:00-05:00,RTIX,neutral
1107878.0,RTI Biologics Guides Q4 Revenue $44-45M vs $45.64M Est,2012-10-25 08:54:00-04:00,RTIX,neutral
1107879.0,RTI Biologics Reports Q3 EPS $0.05 vs $0.04 Est; Revenues $44.6M vs $44.16M Est,2012-10-25 08:52:00-04:00,RTIX,neutral
1107880.0,RTI Biologics Reports Q3 EPS $0.05 vs $0.04 Est; Revenues $44.6M vs $44.16M Est,2012-10-25 08:03:00-04:00,RTIX,neutral
1107881.0,"UPDATE: Benchmark Company Reiterates Buy Rating, Raises PT on RTI Biologics",2012-10-08 11:09:00-04:00,RTIX,neutral
1107882.0,"The Benchmark Company Maintains RTI Biologics at Buy, Raises PT from $4.50 to $5",2012-10-08 06:47:00-04:00,RTIX,neutral
1107883.0,Benzinga's Top Upgrades,2012-08-01 06:43:00-04:00,RTIX,positive
1107884.0,Northland Securities Initiates Coverage On RTI Biologics at Market Perform,2012-06-29 08:11:00-04:00,RTIX,positive
1107885.0,RTI Biologics Reports Q1 EPS $0.04 vs $0.03 Est; Revenues $43.7M vs $41.91M Est,2012-04-26 08:41:00-04:00,RTIX,neutral
1107886.0,"Benchmark Maintains Buy, $4.50 PT on RTI Biologics",2012-02-01 09:29:00-05:00,RTIX,neutral
1107887.0,RTI Biologics Reports Q4 EPS $0.04 vs $0.03 Est,2012-01-31 08:02:00-05:00,RTIX,neutral
1107888.0,Weekly Homework: In Search Of The Santa Claus Rally (w/ Economic Calendar & Stock Radar),2011-12-11 23:22:00-05:00,RTIX,neutral
1107889.0,RTI Biologics Reports Q4 EPS $0.05 vs $0.03 Est; Revenues $42.3M vs $40.44M Est			,2011-10-27 08:17:00-04:00,RTIX,neutral
1107890.0,RTI Biologics and STAAR Surgical End the Week Near 52-Week Highs,2011-08-20 11:37:00-04:00,RTIX,neutral
1107891.0,Stocks to Watch for Wednesday 8/03/2011: Fresh 52 Week Highs and Lows,2011-08-03 01:05:00-04:00,RTIX,positive
1107892.0,UPDATE: Benchmark Upgrades RTI Biologics from Hold to BUY,2011-07-29 08:22:00-04:00,RTIX,neutral
1107894.0,"Benchmark Upgrades RTI Biologics To Buy, $4 PT",2011-07-29 06:00:00-04:00,RTIX,neutral
1107895.0,RTI Biologics Splits Chairman and CEO Roles   ,2011-05-10 16:30:00-04:00,RTIX,neutral
1107896.0,Insiders Predict These 5 Stocks Will Outperform the Market,2010-11-18 13:16:00-05:00,RTIX,neutral
1107897.0,RTI Biologics Announces 2010 Third Quarter Results   ,2010-11-04 08:17:00-04:00,RTIX,neutral
1107898.0, RTI Biologics and Zimmer Dental Enter Distribution Agreement for Global Dental Biologic Implants,2010-09-07 16:04:00-04:00,RTIX,positive
1107899.0,"Stocks Hitting 52-Week Lows (RTIX, SSRI, TTEK, CHRM)",2010-07-19 14:02:00-04:00,RTIX,negative
1107900.0,"Benzinga’s Top Pre-Market Gainers (NIHD, RIGL, APWR, RTIX, ARTG)",2010-02-16 08:37:00-05:00,RTIX,positive
